Ritulasta 500 mg Injection
$407.98
$318.22
Ritulasta 500 mg injection is a potent monoclonal antibody designed to target and modulate the immune system, making it an effective therapeutic option for various conditions, particularly certain hematological malignancies like non-Hodgkin's lymphoma and chronic lymphocytic leukemia. By specifically binding to cancerous cells, Ritulasta helps to inhibit their growth and promotes an immune response against these malignancies. This innovative treatment is administered via injection and is typically prescribed for patients who require targeted therapy in their cancer management plan. It's important to note that while Ritulasta can be beneficial, it may also lead to potential side effects, including infusion reactions and increased risk of infections, necessitating close monitoring by healthcare professionals. Patients should discuss their complete medical history and any current medications with their doctor to ensure safe use. As with any therapeutic regimen, adherence to prescribed dosages and follow-up appointments is crucial for optimal outcomes. Overall, Ritulasta 500 mg injection represents a significant advancement in the fight against specific types of cancer, offering hope for improved patient outcomes.
Quantity
Active Pharmaceutical Ingredient
Uses
• Ritulasta 500 mg injection is utilized in the treatment of Non-Hodgkin lymphoma (NHL), a type of cancer that originates in the lymphatic system. This medication helps target and reduce cancerous cells, thereby improving patient outcomes. It is typically administered in a clinical setting, allowing for close monitoring of the patient's response to therapy. By effectively managing NHL, Ritulasta 500 mg injection can contribute to enhanced quality of life.
• In patients with rheumatoid arthritis, Ritulasta 500 mg injection can play a crucial role in managing symptoms and slowing disease progression. This medication helps to modulate the immune response, reducing inflammation and joint damage. Administered as part of a comprehensive treatment plan, Ritulasta 500 mg injection can significantly improve mobility and reduce pain. This is particularly beneficial for individuals seeking relief from chronic symptoms.
• Ritulasta 500 mg injection is indicated for the treatment of chronic lymphocytic leukaemia (CLL), a type of blood cancer characterized by the accumulation of abnormal lymphocytes. By targeting these cells, Ritulasta 500 mg injection aids in controlling the disease and can lead to a better prognosis. This injection is often part of a multi-faceted approach to cancer management, which may include other therapies. Patients receiving Ritulasta 500 mg injection are typically monitored for effectiveness and adjustments in their treatment regimen.
• The use of Ritulasta 500 mg injection extends to conditions like granulomatosis with polyangiitis and microscopic polyangiitis, which are characterized by inflammation of blood vessels. In these cases, Ritulasta 500 mg injection helps to suppress the aberrant immune response, promoting remission and reducing the risk of flare-ups. This targeted approach can significantly improve patient comfort and overall health. Regular administration of Ritulasta 500 mg injection allows for ongoing management of these complex autoimmune conditions.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Ritulasta 500 mg Injection has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician. Rheumatoid arthritis: Ritulasta 500 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician. Blood cancer (Chronic lymphocytic leukaemia): Leukaemia, also known as blood cancer, is a malignant neoplasm of the haematopoietic tissues that impairs the body's ability to combat infection. Ritulasta 500 Injection is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukaemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment. Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Ritulasta 500 mg Injection is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA. Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Ritulasta 500 Injection reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Ritulasta 500 mg Injection can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Ritulasta 500 mg Injection is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Ritulasta 500 mg. Please consult your doctor.
• Kidney: Ritulasta 500 Injection is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Ritulasta 500 mg Injection is likely to be safe to use while breast-feeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Ritulasta 500 mg Injection is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Ritulasta 500 mg Injection may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Ritulasta 500 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.